Guido O. Pérez

Aortic Pressure Augmentation Predicts Adverse Cardiovascular Events in Patients With Established Coronary Artery Disease

Julio A. Chirinos, Juan P. Zambrano, Simon Chakko et al. · Hypertension · 2005 · 364 citations

Medicine, Cardiology, Internal Medicine +17

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 311 citations

Pharmacy, Pharmacology, Pharmacotherapy +6

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim Harrison, Pascal Chanez, Francesco Menzella et al. · The Lancet Respiratory Medicine · 2020 · 175 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +15

Hepatitis C infection in two urban hemodialysis units

Lennox J. Jeffers, Guido O. Pérez, Maria de Medina et al. · Kidney International · 1990 · 122 citations · Full text

Medicine, Infectious Diseases, Nephrology +10

Leukopenia, hypoxia, and complement function with different hemodialysis membranes

Allan I. Jacob, George Gavellas, R. M. Zarco et al. · Kidney International · 1980 · 119 citations

Medicine, Hematology, Nephrology +14